Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: An analysis from the medicine, angioplasty, or surgery study (MASS II)

Circulation

Volumn 114, Issue SUPPL. 1, 2006, Pages

  Soares, Paulo R ^a   Hueb, Whady A ^a   Lemos, Pedro A ^a   Lopes, Neuza ^a   Martinez, Eulógio E ^a   Cesar, Luis A M ^a   Oliveira, Sergio A ^a   Ramires, Jose A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angioplasty; Coronary disease; Diabetes mellitus; Revascularization; Surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NITRATE; SULFONYLUREA; ANTIDIABETIC AGENT;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MORTALITY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SURGERY; AGED; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DIET THERAPY; HYPERCHOLESTEROLEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LASER ANGIOPLASTY; LIFE TABLE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK; STATISTICS; STENT; SURVIVAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, BALLOON, LASER-ASSISTED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPOGLYCEMIC AGENTS; LIFE TABLES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33747184270     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.000679     Document Type: Article

References (12)

1. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818-1825.
2. Halon DA, Merdler A, Flugelman MY, Rennert HS, Weisz G, Shahla J, Lewis BS. Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center Registry). Am J Cardiol. 2000;85:1420-1426.
3. Weintraub WS, Stein B, Kosinski A, Douglas JS Jr, Ghazzal ZM, Jones EL, Morris DC, Guyton RA, Craver JM, King SB III. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol. 1998;31:10-19.
4. Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation. 1997;96:2551-2556.
5. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000;35:1122-1129.
6. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. Jama. 2005;293:1501-1508.
7. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, Schuler G, Mohr FW, Lindeboom W, Sousa AG, Sousa JE, van Hout B, Hugenholtz PG, Unger F, Serruys PW; Arterial Revascularization Therapy Study Group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation. 2001;104:533-538.
8. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JA. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43:1743-1751.
9. American Diabetes Association. Clinical practice recommendations 1997. Diabetes Care. 1997;20(Suppl 1):S1-S70.
10. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, Culliford AT, Isom OW, Gold JP, Rose EA. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174-2183.
11. Jacobs AK. Coronary revascularization in women in 2003: sex revisited. Circulation. 2003;107:375-377.
12. Sobel BE, Frye R, Detre KM. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation. 2003;107:636-642 (Erratum in: Circulation. 2003;108:500.)